A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol

BACKGROUND: The most commonly applied treatment for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is a 5-day course of high-dose systemic corticosteroids. However, this treatment has not been shown to reduce mortality and can potentially have serious side effects. Recent rese...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Pulm Med
Main Authors: Sivapalan, Pradeesh, Moberg, Mia, Eklöf, Josefin, Janner, Julie, Vestbo, Jørgen, Laub, Rasmus Rude, Browatzki, Andrea, Armbruster, Karin, Wilcke, Jon Torgny, Seersholm, Niels, Weinreich, Ulla Møller, Titlestad, Ingrid Louise, Andreassen, Helle Frost, Ulrik, Charlotte Suppli, Bødtger, Uffe, Nielsen, Thyge Lynghøj, Hansen, Ejvind Frausing, Jensen, Jens Ulrik Stæhr
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5558695/
https://ncbi.nlm.nih.gov/pubmed/28810909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-017-0458-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki